Back to BMY Stock Lookup

BMY – Analyst Ratings

Apr 9, 2014 10:05 AM Gilead (GILD): Goldman Survey Shows Physicians Remain Sensitive to Price (ABBV)
Feb 21, 2014 06:36 AM Edward Jones Downgrades Bristol-Myers Squibb Co. (BMY) to Sell
Feb 10, 2014 07:03 AM BMO Capital Upgrades Bristol-Myers Squibb Co. (BMY) to Outperform
Jan 24, 2014 03:08 PM Bristol-Myers Squibb (BMY) Defended at Goldman Sachs
Jan 13, 2014 03:19 PM Stock Picking More Important This Earnings Than in 10 years - Goldman Sachs
Jan 10, 2014 07:29 AM Barclays Upgrades Bristol-Myers Squibb Co. (BMY) to Overweight
Oct 28, 2013 08:13 AM Morgan Stanley Upgrades Bristol-Myers Squibb Co. (BMY) to Overweight
Oct 8, 2013 04:48 PM Credit Suisse Starts Bristol-Myers Squibb Co. (BMY) at Outperform
Sep 16, 2013 06:41 AM JPMorgan Upgrades Bristol-Myers Squibb Co. (BMY) to Overweight
Aug 30, 2013 02:29 PM Drug Companies on Watch Heading Into ESC Meeting; Goldman Comments (JNJ) (BMY) (PFE)
Jul 12, 2013 08:29 AM Jefferies Downgrades Bristol-Myers Squibb Co. (BMY) to Hold
Jun 26, 2013 08:52 AM MannKind (MNKD) Price Target Raised to $8.40 at Piper
Jun 17, 2013 01:08 PM Supreme Court Ruling Creates Uncertainly for Drug Makers (ACT) (MYL) (MRK)
Jun 3, 2013 03:34 PM Merck (MRK) Immuno-Oncology Offering Lacks Combo; Goldman Maintains Neutral
Jun 3, 2013 11:09 AM Bristol-Myers Squibb (BMY) Immuno-Oncology 'Paradigm Changing' - Goldman
May 29, 2013 04:47 PM SunTrust Robinson Humphrey Starts Bristol-Myers Squibb Co. (BMY) at Buy
May 28, 2013 08:34 AM Jefferies Boosts Price Targets Accross Pharmaceuticals Sector (ABT) (JNJ) (BMY) (more...)
May 22, 2013 06:44 AM Citi Upgrades Bristol-Myers Squibb Co. (BMY) to Buy
May 16, 2013 01:55 PM UPDATE: Leerink Swann Upgrades Bristol-Myers Squibb Co. (BMY) to Outperform
May 16, 2013 07:57 AM Goldman Sees Blockbuster Potential for Bristol-Myers Squibb's (BMY) Nivolumab (PD-1)
May 15, 2013 10:53 AM Bristol-Myers Squibb Company (BMY) Moves Higher Ahead of ASCO Presscast / Abstracts
Apr 10, 2013 08:30 AM Jefferies Lifts PT on Pharmaceuticals Stocks (ABBV) (NVS) (SNY) (PFE)
Apr 1, 2013 11:47 AM Amarin's (AMRN) Vascepa Tracking Well 3-Months In; Investors Eye Tier 2 Designation
Apr 1, 2013 09:37 AM ICON (ICLR) on Watch as Bristol-Myers Squibb (BMY) Adds New Lab Provider
Mar 5, 2013 04:39 PM William Blair Starts Bristol-Myers Squibb Co. (BMY) at Outperform
Mar 4, 2013 07:04 AM BofA/Merrill Lynch Downgrades Bristol-Myers Squibb Co. (BMY) to Neutral
Feb 12, 2013 01:15 PM Bristol-Myers' Baraclude News Could Be Positive for Teva Pharma (TEVA) - Analyst
Dec 31, 2012 08:34 AM Atlantic Equities Upgrades Bristol-Myers Squibb Co. (BMY) to Neutral
Nov 30, 2012 06:51 AM Citi Starts Bristol-Myers Squibb Co. (BMY) at Neutral
Nov 12, 2012 07:19 AM BMO Capital Downgrades Bristol-Myers Squibb Co. (BMY) to Market Perform
Oct 4, 2012 03:17 PM NACF Conference Could Create Catalyst for Vertex (VRTX) - Analyst
Sep 11, 2012 08:17 AM Credit Suisse Starts Bristol-Myers Squibb Co. (BMY) at Neutral
Sep 11, 2012 07:06 AM Goldman Sachs Upgrades Bristol-Myers Squibb Co. (BMY) to Conviction Buy
Aug 30, 2012 10:50 AM UBS Reiterates a 'Buy' on Gilead Sciences (GILD); Raises Numbers on Favorite Large-Cap Biotech
Aug 28, 2012 03:42 PM Barclays on U.S. Biopharmaceuticals: Fate of Nucs Under Harsh Scrutiny - More Angst for IDIX; GILD Widens Lead
Aug 24, 2012 07:58 AM BofA/Merrill Lynch Upgrades Bristol-Myers Squibb Co. (BMY) to Buy
Aug 20, 2012 11:03 AM Amarin (AMRN) NCE Status Could Happen by September 14 and Takeover Could Follow - MKM
Aug 17, 2012 02:54 PM Barclays Lowers Outlook on Idenix Pharmaceuticals (IDIX); Clarity on FDA Clinical Hold (BMY, VRTX, GILD)
Aug 17, 2012 08:46 AM Leerink Swann maintains an 'Outperform' on Idenix Pharmaceuticals (IDIX); Clinical Hold Feels More Like Precaution
Aug 6, 2012 07:29 AM Buy Bristol-Myers (BMY) On Weakness - Jefferies
Aug 2, 2012 01:44 PM UBS on Bristol-Myers Squibb's (BMY) INX-189 Stumble: At Best Puts Bristol Behind; At Worst, Out of the Race
Aug 2, 2012 10:22 AM Barclays Downgrades Bristol-Myers Squibb Co. (BMY) to Equalweight
Aug 2, 2012 08:37 AM Nomura Securities Reiterates a 'Reduce' on AstraZeneca (AZN); Overpayment Risk in Deal with Bristol Myers (BMY)
Jul 20, 2012 03:23 PM UBS Maintains a 'Neutral' on Bristol-Myers Squibb Co. (BMY); Brivanib Misses in HCC
Jul 20, 2012 08:44 AM UPDATE: Onyx Pharma (ONXX) Shares Rise as Leerink Swann Upgrades to Outperform
Jul 16, 2012 09:49 AM S&P 500 (SPY) is Going Higher Because Analyst Carter Worth Says So
Jul 13, 2012 08:32 AM Jefferies on Pharmaceuticals: Global Pharmaceuticals Q2'12 Earnings Preview; Where is it Safe to Hide?
Jul 2, 2012 03:10 PM Barclays on AstraZeneca (AZN): Acquisition of AMLN Makes Strategic Sense but High Price Tag
Jun 26, 2012 08:36 AM Citi Says Buy the Dip in Bristol-Myers (BMY) Shares
Jun 15, 2012 09:09 AM Amylin (AMLN) Wants a Buyout Price At Least in the Low-to-Mid $30s - Jefferies

Back to BMY Stock Lookup